. Military Space News .
SPACE MEDICINE
Nanofiber-based wound dressings induce production of antimicrobial peptide
by Staff Writers
Corvallis OR (SPX) Jul 18, 2018

File image of peptide-nanofibers.

Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections, or SSIs.

The findings by Oregon State University researchers and other collaborators, published Wednesday in Nanomedicine, are important because SSIs are the most common healthcare-associated infection and result in widespread human suffering and economic loss.

Each year in the U.S. alone, nearly 300,000 surgical patients develop an infection within 30 days of their operation - accounting for an estimated $10 billion in additional healthcare costs - and more than 13,000 of those people die.

Researchers used electrospinning to prepare dressings containing the bioactive form of vitamin D: 1,25-dihydroxyvitamin D3, or 1,25(OH)2D3.

"Electrospinning is a versatile, simple, cost-effective and reproducible technique for generating long fibers with nanoscale diameters," said Adrian Gombart, co-corresponding author and professor of biochemistry and biophysics in OSU's College of Science.

"Electrospun nanofiber wound dressings offer significant advantages over hydrogels or sponges for local drug delivery. They provide several functional and structural advantages, including scar-free healing."

The dressings the researchers created proved capable of delivering vitamin D on a sustained basis over four weeks, and they significantly induced production of a peptide, hCAP18/LL37, that kills microbes by disrupting their membranes.

"In past research with nanofiber-based sutures we used the inactive form of vitamin D - which is 25-hydroxyvitamin D3 - and a toll-like receptor ligand that was activating cells to convert 25D3 to the bioactive form, 1,25D3," said the other co-corresponding author, Jingwei Xie, assistant professor at the University of Nebraska Medical Center.

"Here we bypassed that and went straight to the active form. The dressing just released it and it started turning on the vitamin D target genes, one of which produces the LL37 peptide."

Because the dressings work by enhancing innate immune responses rather than by containing conventional, single-target antimicrobial compounds, they are less likely to contribute to drug resistance. The dressings were tested on human skin (collected from plastic surgery patients) in a culture dish, as well as in vitro with keratinocyte and monocyte cell lines, and in vivo in a mouse model.

"This study was proof of principle," said co-author Arup Indra, associate professor of pharmacy at OSU.

"It looks like we can induce the genes in a model system and now we can start looking at healing and infection."

In addition to Indra, Xie and Gombart, a principal investigator at OSU's Linus Pauling Institute, the collaboration also included OSU pharmacy research associate professor Gitali Indra and scientists from the University of California, San Diego, and the VA Nebraska-Western Iowa Health Care System.

"Our study suggests that 1,25D3-induced expression of hCAP18 by these nanofiber dressings is a step forward to improving wound healing," Gitali Indra said.

Research paper


Related Links
Oregon State University
Space Medicine Technology and Systems


Thanks for being here;
We need your help. The Space Media Network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceMediaNetwork Contributor
$5 Billed Once


credit card or paypal
SpaceMediaNetwork Monthly Supporter
$5 Billed Monthly


paypal only


SPACE MEDICINE
MyotonPRO tests muscle tension and stiffness
Paris (ESA) Jul 11, 2018
This gadget looks like a precursor to the devices medical officers use to scan patients in science fiction, and it is not far off. The MyotonPRO tests muscle tension and stiffness. The device is being used on the International Space Station by ESA astronaut Alexander Gerst. Part of the Myotones experiment, Alexander is using the smart-phone-sized device to investigate the human resting muscle tone system. By default, our muscles are always slightly contracted. This is how we maintain posture ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

SPACE MEDICINE
Lockheed contracted for Aegis missile defense development

AEGIS Weapons System sale to Spain approved by State Department

Pentagon awards Lockheed $78M for AEGIS development

Saudi says two Yemen rebel missiles intercepted over Riyadh

SPACE MEDICINE
State Department approves sale of AMRAAM missiles to Denmark

Saudi Arabia says Yemen rebel missile intercepted

NATO successfully tests upgraded Sea Sparrow missile

Finnish navy to acquire Gabriel anti-ship missiles

SPACE MEDICINE
Israel Patriot missile intercepts unarmed drone from Syria: army

Fire Scout unmanned helicopter finishes first flight tests from LCS

Rolls-Royce awarded $420M contract for drone engines

Facebook halts production of drones for internet delivery

SPACE MEDICINE
Altamira receives $25 million contract for radio frequency research

New Land Mobile Technology Driving The Need For Modern Satcom Capabilities

On-the-move communications system set to field this fall

Lockheed Martin's 5th AEHF comsat completes launch environment test

SPACE MEDICINE
Honeywell tapped for M1 tank engine refurbishment

Rheinmetall tapped for laser light for Bundeswehr assault rifles

Lockheed tapped for AN/VSQ-6B sensor system spare parts

Northrop Grumman contracted for mine detection system support

SPACE MEDICINE
Roscosmos Will Not Take Part in Farnborough Airshow in UK

Seven European countries to hit NATO spending pledge: Stoltenberg

Qatar discussed Russian arms deal, but 'no decision': emir

Rolls-Royce sells commercial marine unit

SPACE MEDICINE
Trump attacks US 'foolishness' heading into Putin showdown

Calling EU a US foe is 'fake news': Tusk barb at Trump

Trump lists Russia, EU, China as 'foes' ahead of Putin summit

Trump vows 'extraordinary relationship' with Putin as summit opens

SPACE MEDICINE
Physicists uncover why nanomaterial loses superconductivity

Squeezing light at the nanoscale

A new way to measure energy in microscopic machines

AI-based method could speed development of specialized nanoparticles









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.